This page provides the material available for the Advisory Council meetings held in 2026.
August 3, 2026 — Advisory Council Meeting
During the third meeting of 2026, the Advisory Council heard from a panel organized by the research subcommittee; updates from federal agencies, including an overview of the authorities of the National Institutes of Health, the Food and Drug Administration, and the Centers for Medicare & Medicaid Services; legislative updates from advocacy groups; and an update on the Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease (REMIND) Study. Advisory Council subcommittees also presented their recommendations which were voted on and adopted by the full Advisory Council.
General Material:
Presentation Slides:
- Opening Remarks – Research Subcommittee Chair
- Biomarkers
- The Convergence of Down Syndrome and Alzheimer’s Disease — Scientific and Ethical Imperatives
- Can We Detect and Treat Alzheimer’s Disease a Decade Before Dementia? (And Why We Must!)
- AI and Alzheimer’s Disease
- C-BRAIN AI-Powered Discovery & Potential Applications
- Federal Agency Updates
- The Federal Role in Bringing Breakthrough Treatments to Patients
- The ASAP Act
- The BRIDGE Act
- The CHANGE Act
- Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
- Subcommittee Recommendations
Handouts
Videos
This section includes the recording of the Advisory Council meeting.
- Part 1: Welcome through Research Subcommittee Presentations
- Part 2: Federal Agency Updates through Innovation in Alzheimer’s Disease Interventions
- Part 3: Subcommittee Recommendations
- Part 4: Public Comments through Conclusion
April 27, 2026 — Advisory Council
During the second meeting of 2026, Advisory Council members heard updates from federal agencies on activities during the last quarter and presentations focused on advancements in long-term services and supports and Alzheimer’s disease care. Presenters discussed faith-based and community partnerships in long-term services and support, expanding access to early diagnosis and quality dementia care, the Navigating Aging Needs Navigator Tool, and the Respite for All-faith and community-based care model. The meeting also included a presentation on lessons learned from implementing an innovative service delivery model for people living with Alzheimer’s disease or related dementias and their caregivers.
General Material:
Presentation Slides and Written Updates:
- Federal Agency Updates
- Advancing Early Diagnosis and Dementia Care Through Policy and Advocacy
- Navigating Aging Needs Navigator (NAN) Tool
- Respite for All
- GUIDE Model: Implementation and Early Insights
- Written Updates from Federal Agencies
Videos:
February 9, 2026 — Advisory Council
During the first meeting of 2026, HHS introduced and swore in a new slate of Advisory Council members. Federal agencies provided an overview of their work under the National Alzheimer’s Project Act since 2011, and the Advisory Council discussed a plan for updating the National Plan to Address Alzheimer’s Disease for 2026-2035. The meeting also included presentations on innovative approaches in Alzheimer's disease interventions.
General Material:
Presentation Slides:
- National Alzheimer’s Project Act Overview
- New Federal Agency Partners SSA
- Federal Agency Roles and Progress Part 1: NIH, FDA, NSF, DOW, CMS
- Federal Agency Roles and Progress Part 2: ACL, HRSA, CDC
- Ten Years of Transformative Progress in Alzheimer's Dementia Research: From DIAN Insights to AI-Powered Discovery: Alzheimer’s Prevention, Aging, and Artificial Intelligence
- Federal Agency Roles and Progress Part 3: IHS, AHRQ, SAMHSA, ASPE
- Robotic Surgical Procedure to Address Alzheimer’s
- Approach to Updating National Plan for 2026-2035
Handouts:
Videos:
- Part 1, Welcome through Federal Agency Roles and Progress: Part 1
- Part 2, “Ten Years of Transformative Progress in Alzheimer's Dementia Research” through Federal Agency Roles and Progress: Part 2
- Part 3, Federal Agency Roles and Progress: Part 3 through Conclusion
Comments and questions, or alerts to broken links, should be sent to napa@hhs.gov.